1.
Ocio EM, Efebera YA, Hájek R, Straub J, Maisnar V, Eveillard J-R, Karlin L, Mateos M-V, Oriol A, Ribrag V, Richardson PG, Norin S, Obermüller J, Bakker NA, Pour L. ANCHOR: melflufen plus dexamethasone and daratumumab or bortezomib in relapsed/refractory multiple myeloma: final results of a phase I/IIa study. haematol [Internet]. 2024Mar.1 [cited 2024May25];109(3):867-76. Available from: https://haematologica.org/article/view/haematol.2023.283490